[go: up one dir, main page]

PT1076650E - Compostos azapoliciclicos fundidos com arilo - Google Patents

Compostos azapoliciclicos fundidos com arilo

Info

Publication number
PT1076650E
PT1076650E PT99910600T PT99910600T PT1076650E PT 1076650 E PT1076650 E PT 1076650E PT 99910600 T PT99910600 T PT 99910600T PT 99910600 T PT99910600 T PT 99910600T PT 1076650 E PT1076650 E PT 1076650E
Authority
PT
Portugal
Prior art keywords
azapolicylic
arylo
cast
compounds
compounds cast
Prior art date
Application number
PT99910600T
Other languages
English (en)
Inventor
Jotham Wadsworth Coe
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of PT1076650E publication Critical patent/PT1076650E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22Bridged ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34Tobacco-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Cardiology (AREA)
  • Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
PT99910600T 1998-04-29 1999-04-08 Compostos azapoliciclicos fundidos com arilo PT1076650E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8355698P 1998-04-29 1998-04-29

Publications (1)

Publication Number Publication Date
PT1076650E true PT1076650E (pt) 2004-05-31

Family

ID=22179102

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99910600T PT1076650E (pt) 1998-04-29 1999-04-08 Compostos azapoliciclicos fundidos com arilo

Country Status (41)

Country Link
US (3) US6462035B1 (pt)
EP (1) EP1076650B1 (pt)
JP (1) JP2002513007A (pt)
KR (1) KR100420423B1 (pt)
CN (1) CN1144787C (pt)
AP (1) AP1154A (pt)
AR (1) AR018596A1 (pt)
AT (1) ATE258921T1 (pt)
AU (1) AU749831B2 (pt)
BG (1) BG64556B1 (pt)
BR (1) BR9910058A (pt)
CA (1) CA2330576A1 (pt)
CO (1) CO5021124A1 (pt)
DE (1) DE69914594T2 (pt)
DK (1) DK1076650T3 (pt)
DZ (1) DZ2778A1 (pt)
EA (1) EA003669B1 (pt)
ES (1) ES2213354T3 (pt)
GT (1) GT199900059A (pt)
HR (1) HRP20000731A2 (pt)
HU (1) HUP0103340A3 (pt)
ID (1) ID26700A (pt)
IL (1) IL138917A0 (pt)
IS (1) IS5649A (pt)
MA (1) MA26623A1 (pt)
MY (1) MY133474A (pt)
NO (1) NO317300B1 (pt)
NZ (1) NZ507035A (pt)
OA (1) OA11506A (pt)
PA (1) PA8471301A1 (pt)
PE (1) PE20000435A1 (pt)
PL (1) PL344010A1 (pt)
PT (1) PT1076650E (pt)
SK (1) SK15952000A3 (pt)
TN (1) TNSN99080A1 (pt)
TR (1) TR200003122T2 (pt)
UA (1) UA61991C2 (pt)
UY (1) UY25636A1 (pt)
WO (1) WO1999055680A1 (pt)
YU (1) YU64400A (pt)
ZA (1) ZA992971B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ME00459B (me) * 1997-12-31 2011-10-10 Pfizer Prod Inc Aril fuzirana azapoliciklična jedinjenja
US6605610B1 (en) * 1997-12-31 2003-08-12 Pfizer Inc Aryl fused azapolycyclic compounds
US20010036943A1 (en) * 2000-04-07 2001-11-01 Coe Jotham W. Pharmaceutical composition for treatment of acute, chronic pain and/or neuropathic pain and migraines
YU78303A (sh) * 2001-04-20 2006-05-25 Pfizer Products Inc. Postupak za dobijanje 1,3-supstituisanih indena i azapolicikličnih jedinjenja sa pripojenim arilom
SK1912004A3 (en) * 2001-10-31 2004-09-08 Pfizer Prod Inc Nicotinic acetylcholine receptor agonists in the treatment of restless legs syndrome
RU2004116320A (ru) 2001-11-30 2005-10-10 Пфайзер Продактс Инк. (Us) Арилконденсированные азаполициклические соединения
AU2003233228A1 (en) * 2002-05-03 2003-11-17 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Novel spiro ketone and carboxylic acid derivatives as specific inhibitors for (po3h2) ser/(po3h2)thr-pro-specific peptidyl-prolyl-cis/trans-isomerases
US20040224963A1 (en) * 2003-05-09 2004-11-11 Pfizer Inc Pharmaceutical composition for the prevention and treatment of nicotine addiction in a mammal
US20040224962A1 (en) * 2003-05-09 2004-11-11 Pfizer Inc Pharmaceutical composition for the treatment of obesity or to facilitate or promote weight loss
JP2006528170A (ja) * 2003-07-21 2006-12-14 ファイザー・プロダクツ・インク アリール縮合型アザ多環式化合物
EP1648893B1 (en) * 2003-07-21 2009-09-23 Pfizer Products Inc. Nicotine addiction reducing heteroaryl fused azapolycyclic compounds
US20050043407A1 (en) * 2003-08-22 2005-02-24 Pfizer Inc Pharmaceutical composition for the prevention and treatment of addiction in a mammal
CA2591330A1 (en) * 2004-12-07 2006-06-15 Pfizer Products Inc. 1, 2, 3, 3a, 8, 8a-hexahydro-2, 7a-diada-cyclopenta [a] inden-7-one derivatives which bind to neuronal nicotinic acetylcholine specific receptor sites and are useful in modulatingcholinergic function and in the treatment of addictive disorders
US20060210497A1 (en) * 2005-03-18 2006-09-21 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Novel resorcinol derivatives
US20060210498A1 (en) 2005-03-18 2006-09-21 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Novel resorcinol derivatives for skin
DE102005061426A1 (de) * 2005-12-22 2007-07-05 Grünenthal GmbH Substituierte tricyclische Piperidon-Derivate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3687937A (en) * 1970-06-23 1972-08-29 Us Of America The 1,5-methano-3-benzazocine derivatives
JPS4914473A (pt) * 1972-06-09 1974-02-07
JPS4924968A (pt) * 1972-07-01 1974-03-05

Also Published As

Publication number Publication date
DE69914594D1 (de) 2004-03-11
NO20005397D0 (no) 2000-10-26
AP1154A (en) 2003-03-27
TR200003122T2 (tr) 2001-03-21
SK15952000A3 (sk) 2002-06-04
UA61991C2 (en) 2003-12-15
PA8471301A1 (es) 2000-09-29
YU64400A (sh) 2003-01-31
BG104983A (en) 2001-09-28
CA2330576A1 (en) 1999-11-04
EP1076650B1 (en) 2004-02-04
US6462035B1 (en) 2002-10-08
UY25636A1 (es) 2000-02-23
ATE258921T1 (de) 2004-02-15
CN1144787C (zh) 2004-04-07
KR100420423B1 (ko) 2004-03-04
OA11506A (en) 2004-05-14
US20030008890A1 (en) 2003-01-09
US7122534B2 (en) 2006-10-17
WO1999055680A1 (en) 1999-11-04
DE69914594T2 (de) 2004-12-09
IL138917A0 (en) 2001-11-25
EP1076650A1 (en) 2001-02-21
KR20010043143A (ko) 2001-05-25
DZ2778A1 (fr) 2005-04-23
DK1076650T3 (da) 2004-05-24
GT199900059A (es) 2000-10-11
NZ507035A (en) 2003-05-30
EA200000996A1 (ru) 2001-06-25
MA26623A1 (fr) 2004-12-20
HUP0103340A2 (hu) 2002-02-28
BG64556B1 (bg) 2005-07-29
IS5649A (is) 2000-09-29
CO5021124A1 (es) 2001-03-27
HUP0103340A3 (en) 2002-10-28
PL344010A1 (en) 2001-09-24
US6706702B2 (en) 2004-03-16
MY133474A (en) 2007-11-30
AP9901524A0 (en) 1999-06-30
PE20000435A1 (es) 2000-05-26
EA003669B1 (ru) 2003-08-28
US20040167149A1 (en) 2004-08-26
AU2951699A (en) 1999-11-16
TNSN99080A1 (fr) 2005-11-10
AU749831B2 (en) 2002-07-04
NO317300B1 (no) 2004-10-04
ZA992971B (en) 2000-10-30
JP2002513007A (ja) 2002-05-08
BR9910058A (pt) 2000-12-26
ID26700A (id) 2001-02-01
HRP20000731A2 (en) 2001-06-30
NO20005397L (no) 2000-10-26
AR018596A1 (es) 2001-11-28
CN1298394A (zh) 2001-06-06
ES2213354T3 (es) 2004-08-16
HK1036453A1 (en) 2002-01-04

Similar Documents

Publication Publication Date Title
FI982066A0 (fi) Sylinterilukko-avain-yhdistelmä
DE69917850D1 (de) Batterie-Verbindungsplatte
LTPA2009006I1 (lt) Trombopoetino junginiai
ATE229954T1 (de) Betacarbolinverbindungen
ID28266A (id) Senyawa-senyawa amidin
DE59905573D1 (de) Polsterträger
ID26899A (id) Turunan-turunan tiobenzimidazol
DE69900821D1 (de) Modifizierter kurbelmechanismus
NO20011745L (no) Forbindelser
ID23287A (id) Trisiklik tersubstitusi
ID24221A (id) Tempat patrum
DE69902762D1 (de) Riser-spannanordnung
NO20005006L (no) Kalsilytiske forbindelser
PT1076650E (pt) Compostos azapoliciclicos fundidos com arilo
DE59912684D1 (de) Folienförmige wirkstoffträger
ID23219A (id) Trisiklik tersubstitusi
EP1005862A4 (en) ANTI-CHLAMYDIA MEDIUM
NO20006662L (no) Fluorfenylresin-forbindelser
DE69936771D1 (de) Microencapsulierte lewis-saueren
ATE217021T1 (de) Präparationsmittel
DE59911610D1 (de) Substituierte benzoylcyclohexandione
ATE237420T1 (de) Giessrohr
ATE303996T1 (de) Substituierte acylaminophenyl-uracile
DE59912188D1 (de) Substituierte phenyluracile
DE59900001D1 (de) Kombinationswaage